Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity

Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity

Obesity adversely impacts millions of American adults by predisposing them to significant health risks and further complications. Obesity is differentiated into two groups: metabolically healthy and metabolically unhealthy. In contrast to metabolically healthy counterparts, obese individuals who are...

Full description

Bibliographic Details
Main Authors: Melissa A. Burmeister, Tara E. Smith, Timothy K. Fincher, Abby J. Weldon
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Endocrinology
Subjects:
proton-pump inhibitor (PPI)
metabolically unhealthy obesity (MUO)
dysbiosis
inflammation
butyrate
short-chain fatty acids (SCFAs)
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1205490/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1205490/full

Similar Items